Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and Ad… Recruiting

2024-512321-84-00 Patients after HSCT suffering from new or reactivated C 5 2019-10-02
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Maribav… Ended

2025-523487-21-00 cytomegalovirus (CMV) infection and/or disease that is 2 2026-05-05
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
Phase 3 Study to Evaluate Brelovitug vs Delayed Treatment for Treatment of Chronic Hepatitis Delta Infection (AZURE-4) Ended

2025-522105-38-00 Chronic Hepatitis Delta Infection 5 2026-02-02
Phase I Study of Plitidepsin Administered Intravenously as a Single Dose in Healthy Volunteers Ended

2024-513664-25-00 Virus diseases 3 2026-01-26
Safety, tolerance and antiretroviral activity of IMP: a pilot clinical trial in patients with recent HIV-1 infection Ended

2024-519641-30-00 Asymptomatic patients with recent HIV-1 infection 4 2026-01-26
Effect of COV2 vaccine formulation on the ability to generate antibodies against coronavirus Ended

2025-523712-37-00 Booster immunisation against COVID-19 disease caused by 3 2026-01-21
A Phase 4 Pragmatic, Randomized Trial to Evaluate the Effectiveness and Safety of mRNA-1273 Variant-Containing Vaccine Formulation Against S… Ended

2025-523841-82-00 SARS-CoV-2 infection 6 2025-12-11
A clinical study of MK-8527 to prevent HIV-1 (MK-8527-011) Ended

2025-520610-58-00 HIV-1 prevention 5 2025-11-19
A study to assess the immune response and safety of a vaccine against influenza in adults 18 years of age and older Ended

2025-522599-97-00 Influenza, Human 4 2025-10-30
A study to test the safety, dosage and effectiveness of maribavir for the treatment of cytomegalovirus (CMV) infection in children and adole… Ended

2023-508988-73-00 Cytomegalovirus (CMV) infection in children and adolesc 5 2025-10-29
A Phase 3 Study to Assess the Safety and Immunogenicity of High-dose Influenza Vaccine in Adults ≥ 60 years of Age Ended

2024-519743-15-00 Influenza immunisation 5 2025-10-20
Immunogenicity of Licensed zoonotic influenza vaccine in primed and naive participants. Ended

2025-522593-36-00 Virus Diseases 6 2025-10-15
A Phase 3 Trial Comparing Whether BEM/RZR is Similar to SOF/VEL in Patients with Hepatitis C Virus Infection Ended

2025-521096-31-00 Chronic Hepatitis C Virus (HCV) Infection 5 2025-10-02
An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachmen… Ended

2025-520629-19-00 HIV Infections 3 2025-10-01
Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1 Ended

2024-520159-26-00 Human immunodeficency virus 4 2025-09-17
Implementation RSV Immunization Study (IRIS) Ended

2025-521801-42-00 Healthy infants receiving an RSV immunization to preven 6 2025-08-27
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV Infection Ended

2024-520062-54-00 Chronic Hepatitis D Virus (HDV) Infection 4 2025-07-23
TherVacB_Phase1a: Open phase 1a trial to assess the safety and immunogenicity of a heterologous protein prime/MVA boost therapeutic hepatiti… Ended

2024-514231-26-00 Chronic Hepatitis B 1 2025-07-08
A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatit… Ended

2024-519063-18-00 Chronic Hepatitis Delta Infection 10 2025-06-24
A phase 1/2a multicenter trial to evaluate the safety and immunogenicity of the CD40.Pan.CoV vaccine, adjuvanted or not, as a booster in adu… Ended

2024-516767-92-01 Health Participants 1 2025-06-17
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating the Efficacy of Transfer Factor TFI Treatment by Assessing the Numb… Ended

2024-516879-32-00 • Recurrent respiratory infections • Recurrent urinary 5 2025-06-13
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection Ended

2024-515919-22-00 Chronic Hepatitis D Virus (HDV) Infection 5 2025-06-02
A study to assess the safety and immunogenicity of a therapeutic hepatitis B virus vaccine, in healthy adults (RUBY). Ended

2025-521169-28-00 Hepatitis B 1 2025-05-06